MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

6 Things You Should Know About the Emerging TMVR Market MD+DI/Amanda Pedersen
The transcatheter mitral valve replacement market is still in its infancy, according to Jason Mills, a medtech analyst at Canaccord Genuity.

6 Things You Should Know About the Emerging TMVR Market

Canaccord Genuity's Jason Mills shares these important themes from his deep-dive analysis on the transcathter mitral valve replacement (TMVR) market. Mills notes a multibillion-dollar market opportunity, but the field must overcome several hurdles to realize the full TMVR potential.

For recent MD+DI coverage on the promising field of transcatheter mitral valve replacement/repair, check out these stories:

Abbott Wins Additional Indication for MitraClip

Cardiovalve Makes Crucial Move in TMVR Market

Abbott Makes Strong Statement in TMVR Space with SUMMIT

LivaNova Looks to Be a Standout Firm in TMVR

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish